These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Prophylaxis of peritonitis in continuous ambulatory peritoneal dialysis. Záruba K Lancet; 1982 Jan; 1(8264):162. PubMed ID: 6119531 [No Abstract] [Full Text] [Related]
44. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719 [TBL] [Abstract][Full Text] [Related]
46. Brucella peritonitis in a patient on peritoneal dialysis. Alothman A; Al Khurmi A; Al Sadoon S; AlHejaili F Saudi J Kidney Dis Transpl; 2008 May; 19(3):428-30. PubMed ID: 18445904 [TBL] [Abstract][Full Text] [Related]
47. Rates and causes of peritonitis in a National Multicenter Continuous Ambulatory Peritoneal Dialysis program in Sudan: first-year experience. Abu-Aisha H; Elhassan EA; Khamis AH; Fedail H; Kaballo B; Abdelraheem MB; Ali T; Medani S; Tammam L; Basheir I Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):565-70. PubMed ID: 17951944 [TBL] [Abstract][Full Text] [Related]
48. Changes in the organisms of resistant peritonitis in patients on continuous ambulatory peritoneal dialysis. Nakamoto H; Hashikita Y; Itabashi A; Kobayashi T; Suzuki H Adv Perit Dial; 2004; 20():52-7. PubMed ID: 15384795 [TBL] [Abstract][Full Text] [Related]
49. Can we reduce rates of Staphylococcus aureus and other peritonitis in peritoneal dialysis patients? Piraino B Perit Dial Int; 2010; 30(3):277-9. PubMed ID: 20424197 [No Abstract] [Full Text] [Related]
51. An update on the continuous ambulatory peritoneal dialysis (CAPD). Oreopoulos DG Int J Artif Organs; 1980 Jul; 3(4):231-4. PubMed ID: 7409921 [No Abstract] [Full Text] [Related]
52. Experience with continuous ambulatory peritoneal dialysis (CAPD). Oreopoulos DG; Clayton S; Dombros N; Zellerman G; Katirtzoglou A Trans Am Soc Artif Intern Organs; 1979; 25():95-9. PubMed ID: 524646 [No Abstract] [Full Text] [Related]
53. Use of povidone iodine in continuous ambulatory peritoneal dialysis (CAPD) -- a technique to reduce the incidence of infectious peritonitis. Yee E; Foss K; Schmidt RW Trans Am Soc Artif Intern Organs; 1980; 26():223-4. PubMed ID: 7245488 [No Abstract] [Full Text] [Related]
54. Establishing a CAPD program. III. Nursing management in continuous ambulatory peritoneal dialysis. McFarland SC Nephrol Nurse; 1981; 3(2):48-51. PubMed ID: 6907689 [No Abstract] [Full Text] [Related]
55. Acute peritoneal dialysis in children. Yahav J; Barzilay Z; Aladjem M; Baron Z; Boichis H Int J Pediatr Nephrol; 1981 Mar; 2(1):33-5. PubMed ID: 7333767 [No Abstract] [Full Text] [Related]
56. Reactive arthritis associated with Staphylococcus epidermidis peritonitis in patient undergoing continuous ambulatory peritoneal dialysis. Hughes BR; Hind CR Br Med J (Clin Res Ed); 1983 Jan; 286(6360):188-9. PubMed ID: 6401523 [No Abstract] [Full Text] [Related]
57. Exacerbation of extrarenal systemic lupus erythematosus following peritonitis in peritoneal dialysis. Servilla KS; Tzamaloukas AH Perit Dial Int; 2003; 23(1):96-7. PubMed ID: 12691519 [No Abstract] [Full Text] [Related]